MRI용 인공지능(AI) 시장 : 전략적 인사이트 및 예측(2026-2031년)

The Global Artificial Intelligence in MRI market is forecast to grow at a CAGR of 18.0%, reaching USD 3.2 billion in 2031 from USD 1.4 billion in 2026.

The artificial intelligence in MRI market is emerging as a critical component of digital healthcare transformation. Integration of AI into magnetic resonance imaging systems enhances diagnostic accuracy, operational efficiency, and clinical workflow management. Healthcare providers are increasingly leveraging AI to process large imaging datasets, improve detection of disease patterns, and optimize imaging procedures. The market reflects a broader shift toward precision medicine, data-driven diagnostics, and patient-centric care models.

Growth in healthcare digitization, rising imaging volumes, and increasing demand for advanced diagnostic capabilities are strengthening adoption across hospitals and diagnostic facilities. AI-powered MRI technologies enable improved image reconstruction, automated workflow support, and faster scan interpretation. As healthcare systems face rising demand for timely diagnosis and cost-effective treatment, AI integration is becoming a strategic priority for imaging providers and technology vendors.

Market Drivers

Rising prevalence of chronic diseases is a primary growth catalyst. Increasing incidence of cancer, cardiovascular disorders, and neurological conditions requires advanced diagnostic imaging capabilities. AI enhances MRI performance by improving disease detection accuracy and enabling earlier clinical intervention.

Technological advancement in healthcare infrastructure is another major driver. Governments and healthcare organizations are supporting the integration of artificial intelligence into medical imaging systems. AI improves scan quality, reduces examination time, and enhances patient comfort, which supports broader adoption across clinical environments.

Growing demand for efficiency in radiology departments also contributes to market expansion. AI enables automation of routine tasks, reduces radiologist workload, and accelerates reporting timelines. This improves service capacity and supports improved patient management.

In addition, increasing adoption of point-of-care imaging and portable MRI technologies is creating new application opportunities. AI-powered denoising and workflow optimization tools enhance imaging performance across diverse clinical settings.

Market Restraints

Despite strong growth potential, implementation complexity remains a challenge. Integration of AI into clinical imaging infrastructure requires investment in software systems, technical expertise, and workflow redesign. These requirements may limit adoption among smaller healthcare facilities.

Data management and system compatibility also present operational barriers. MRI systems generate large volumes of imaging data that must be processed, stored, and analyzed efficiently. Ensuring interoperability between imaging equipment and AI platforms can be technically demanding.

In addition, reliance on advanced algorithms and specialized training requirements may increase implementation costs and slow deployment in resource-constrained environments.

Technology and Segment Insights

The market is segmented by solution into software and services. Software solutions form the core of AI-enabled MRI, supporting image reconstruction, denoising, workflow automation, and clinical decision support. Services include implementation, maintenance, and system integration.

By end-user, hospitals account for a significant share due to high imaging volumes and demand for advanced diagnostic capabilities. Clinics and diagnostic centers also represent important adoption segments as imaging services expand across outpatient settings.

Technological development focuses on deep learning and advanced algorithms designed to improve image clarity, automate positioning, and enhance scan precision. AI applications are also advancing in portable imaging and point-of-care diagnostics, supporting wider accessibility.

Geographically, North America maintains a leading market share, supported by strong healthcare infrastructure, technology adoption, and research collaboration initiatives.

Competitive and Strategic Outlook

The competitive landscape includes major medical technology and AI solution providers focusing on innovation, partnerships, and product development. Companies are investing in advanced imaging platforms and collaborative research initiatives to enhance clinical performance and expand application areas.

Strategic alliances between healthcare institutions and technology vendors are accelerating development of specialized MRI applications, including cardiac imaging and workflow automation. Continuous research and development remain central to competitive positioning as vendors seek to deliver faster, more accurate imaging systems.

Key Takeaways

The artificial intelligence in MRI market is positioned for sustained expansion as healthcare providers prioritize diagnostic precision and operational efficiency. Technological innovation and increasing disease burden will continue to drive adoption. However, implementation complexity and system integration challenges remain key considerations. Continued investment in research, infrastructure, and clinical collaboration will shape long-term market development.

Key Benefits of this Report

• Insightful Analysis: Gain detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
• Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
• Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
• Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
• Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What businesses use our reports for

Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

• Historical data from 2021 to 2025 and forecast data from 2026 to 2031
• Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
• Competitive positioning, strategies, and market share evaluation
• Revenue growth and forecast assessment across segments and regions
• Company profiling including strategies, products, financials, and key developments

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key Benefits for the Stakeholders

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Process
• 2.3. Data Validation

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. Analyst View

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Supplier
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. ARTIFICIAL INTELLIGENCE (AI) IN MRI MARKET BY SOLUTION

• 5.1. Introduction
• 5.2. Software
• 5.3. Services

6. ARTIFICIAL INTELLIGENCE (AI) IN MRI MARKET BY END-USER

• 6.1. Introduction
• 6.2. Hospitals
• 6.3. Clinics
• 6.4. Diagnostic Centers

7. ARTIFICIAL INTELLIGENCE (AI) IN MRI MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. By Type
  • 7.2.2. By Industry Vertical
  • 7.2.3. By Country
    • 7.2.3.1. USA
    • 7.2.3.2. Canada
    • 7.2.3.3. Mexico
• 7.3. South America
  • 7.3.1. By Type
  • 7.3.2. By Industry Vertical
  • 7.3.3. By Country
    • 7.3.3.1. Brazil
    • 7.3.3.2. Argentina
    • 7.3.3.3. Others
• 7.4. Europe
  • 7.4.1. By Type
  • 7.4.2. By Industry Vertical
  • 7.4.3. By Country
    • 7.4.3.1. United Kingdom
    • 7.4.3.2. Germany
    • 7.4.3.3. France
    • 7.4.3.4. Spain
    • 7.4.3.5. Others
• 7.5. Middle East and Africa
  • 7.5.1. By Type
  • 7.5.2. By Industry Vertical
  • 7.5.3. By Country
    • 7.5.3.1. Saudi Arabia
    • 7.5.3.2. UAE
    • 7.5.3.3. Others
• 7.6. Asia Pacific
  • 7.6.1. By Type
  • 7.6.2. By Industry Vertical
  • 7.6.3. By Country
    • 7.6.3.1. China
    • 7.6.3.2. Japan
    • 7.6.3.3. India
    • 7.6.3.4. South Korea
    • 7.6.3.5. Australia
    • 7.6.3.6. Singapore
    • 7.6.3.7. Indonesia
    • 7.6.3.8. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Emerging Players and Market Lucrativeness
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Competitive Dashboard

9. COMPANY PROFILES

• 9.1. Siemens Healthineers AG
• 9.2. GE HealthCare
• 9.3. IBM
• 9.4. Philips Healthcare
• 9.5. NVIDIA Corporation
• 9.6. Oxipit.ai
• 9.7. Quibim
• 9.8. Intel
• 9.9. AWS
• 9.10. Google Cloud
• 9.11. Aikenist Technologies Pvt. Ltd.
• 9.12. CARPL.ai
• 9.13. Subtle Medical, Inc.